Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 134

1.

Assessment and hormonal management of osteoporosis.

Trémollieres F.

Climacteric. 2019 Apr;22(2):122-126. doi: 10.1080/13697137.2018.1555582. Epub 2019 Jan 9.

PMID:
30624083
2.

[Towards an optimization of the modulation of the estrogen receptor during menopausal hormonal therapy].

Valéra MC, Fontaine C, Noirrit-Esclassan E, Boudou F, Buscato M, Adlanmerini M, Trémollières F, Gourdy P, Lenfant F, Arnal JF.

Med Sci (Paris). 2018 Dec;34(12):1056-1062. doi: 10.1051/medsci/2018297. Epub 2019 Jan 9. French.

PMID:
30623764
3.

2018 update of French recommendations on the management of postmenopausal osteoporosis.

Briot K, Roux C, Thomas T, Blain H, Buchon D, Chapurlat R, Debiais F, Feron JM, Gauvain JB, Guggenbuhl P, Legrand E, Lehr-Drylewicz AM, Lespessailles E, Tremollieres F, Weryha G, Cortet B.

Joint Bone Spine. 2018 Oct;85(5):519-530. doi: 10.1016/j.jbspin.2018.02.009. Epub 2018 Apr 11.

4.

[Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer].

Rousset-Jablonski C, Selle F, Adda-Herzog E, Planchamp F, Selleret L, Pomel C, Chabbert-Buffet N, Daraï E, Pautier P, Trémollières F, Guyon F, Rouzier R, Laurence V, Chopin N, Faure-Conter C, Bentivegna E, Vacher-Lavenu MC, Lhomme C, Floquet A, Treilleux I, Lecuru F, Gouy S, Kalbacher E, Genestie C, de la Motte Rouge T, Ferron G, Devouassoux-Shisheboran M, Kurtz JE, Namer M, Joly F, Pujade-Lauraine E, Grynberg M, Querleu D, Morice P, Gompel A, Ray-Coquard I.

Bull Cancer. 2018 Mar;105(3):299-314. doi: 10.1016/j.bulcan.2017.10.032. French.

PMID:
29397916
5.

Estetrol, a Fetal Selective Estrogen Receptor Modulator, Acts on the Vagina of Mice through Nuclear Estrogen Receptor α Activation.

Benoit T, Valera MC, Fontaine C, Buscato M, Lenfant F, Raymond-Letron I, Tremollieres F, Soulie M, Foidart JM, Game X, Arnal JF.

Am J Pathol. 2017 Nov;187(11):2499-2507. doi: 10.1016/j.ajpath.2017.07.013. Epub 2017 Aug 19.

PMID:
28827141
6.

Diagnostic accuracy of FRAX in predicting the 10-year risk of osteoporotic fractures using the USA treatment thresholds: A systematic review and meta-analysis.

Jiang X, Gruner M, Trémollieres F, Pluskiewicz W, Sornay-Rendu E, Adamczyk P, Schnatz PF.

Bone. 2017 Jun;99:20-25. doi: 10.1016/j.bone.2017.02.008. Epub 2017 Mar 6. Review.

PMID:
28274799
7.

French law: what about a reasoned reimbursement of serum vitamin D assays?

Souberbielle JC, Benhamou CL, Cortet B, Rousière M, Roux C, Abitbol V, Annweiler C, Audran M, Bacchetta J, Bataille P, Beauchet O, Bardet R, Benachi A, Berenbaum F, Blain H, Borson-Chazot F, Breuil V, Briot K, Brunet P, Carel JC, Caron P, Chabre O, Chanson P, Chapurlat R, Cochat P, Coutant R, Christin-Maitre S, Cohen-Solal M, Combe C, Cormier C, Courbebaisse M, Debrus G, Delemer B, Deschenes G, Duquenne M, Duval G, Fardellone P, Fouque D, Friedlander G, Gauvain JB, Groussin L, Guggenbuhl P, Houillier P, Hannedouche T, Jacot W, Javier RM, Jean G, Jeandel C, Joly D, Kamenicky P, Knebelmann B, Lafage-Proust MH, LeBouc Y, Legrand E, Levy-Weil F, Linglart A, Machet L, Maheu E, Mallet E, Marcelli C, Marès P, Mariat C, Maruani G, Maugars Y, Montagnon F, Moulin B, Orcel P, Partouche H, Personne V, Pierrot-Deseilligny C, Polak M, Pouteil-Noble C, Prié D, Raynaud-Simon A, Rolland Y, Sadoul JL, Salle B, Sault C, Schott AM, Sermet-Gaudelus I, Soubrier M, Tack I, Thervet E, Tostivint I, Touraine P, Tremollières F, Urena-Torres P, Viard JP, Wemeau JL, Weryha G, Winer N, Young J, Thomas T.

Geriatr Psychol Neuropsychiatr Vieil. 2016 Dec 1;14(4):377-382. Review.

PMID:
27818369
8.

Reimbursment of the serum CTX assay in France: the clinical biology nomenclature is incoherent.

Souberbielle JC, Bendavid S, Blain H, Bousson V, Breuil V, Briot K, Chapurlat R, Chapuis L, Cohen-Solal M, Fardellone P, Feron JM, Gauvain JB, Laroche M, Legrand E, Lespessailles E, Linglart A, Marcelli C, Roux C, Sutter B, Thomas T, Trémollières F, Weryha G, Cortet B.

Ann Biol Clin (Paris). 2016 Aug 1;74(4):381-3. doi: 10.1684/abc.2016.1162. No abstract available.

PMID:
27492690
9.

Diminished bone resorption in overweight/obese women despite vitamin D insufficiency.

Laroche M, Pouilles JM, Trémollières F, Vallet M, Lassoued S, Nigon D, Tack I.

Joint Bone Spine. 2017 Jan;84(1):119-120. doi: 10.1016/j.jbspin.2016.03.001. Epub 2016 Apr 23. No abstract available.

PMID:
27118019
10.

Hormone therapy and ovarian cancer.

Trémollieres F, Lopès P, Gompel A; Groupe d'Etude sur la Ménopause et le Vieillissement hormonal.

Lancet. 2015 Sep 12;386(9998):1038. doi: 10.1016/S0140-6736(15)00139-7. No abstract available.

PMID:
26382992
11.

Non-hormonal management of menopausal vasomotor symptoms: Psychosocial interventions.

Mintziori G, Goulis DG, Lambrinoudaki I, Ceausu I, Depypere H, Erel CT, Pérez-López FR, Schenck-Gustafsson K, Simoncini T, Tremollieres F, Rees M.

Maturitas. 2015 Dec;82(4):444-5. doi: 10.1016/j.maturitas.2015.08.011. Epub 2015 Sep 5. No abstract available.

PMID:
26351142
12.

[Association of estrogens and selective estrogens receptors modulators: towards a renewal of the hormonal treatment?].

Valéra MC, Chantalat E, Vinel A, Benoit T, Guillaume M, Game X, Gourdy P, Trémollières F, Payrastre B, Arnal JF.

Presse Med. 2015 Jul-Aug;44(7-8):805-11. doi: 10.1016/j.lpm.2015.07.003. Epub 2015 Aug 13. Review. French.

PMID:
26278157
13.

From the Women's Health Initiative to the combination of estrogen and selective estrogen receptor modulators to avoid progestin addition.

Valera MC, Gourdy P, Trémollières F, Arnal JF.

Maturitas. 2015 Nov;82(3):274-7. doi: 10.1016/j.maturitas.2015.07.012. Epub 2015 Jul 26. Review.

PMID:
26261036
14.

EMAS position statement: Non-hormonal management of menopausal vasomotor symptoms.

Mintziori G, Lambrinoudaki I, Goulis DG, Ceausu I, Depypere H, Erel CT, Pérez-López FR, Schenck-Gustafsson K, Simoncini T, Tremollieres F, Rees M.

Maturitas. 2015 Jul;81(3):410-3. doi: 10.1016/j.maturitas.2015.04.009. Epub 2015 Apr 22. Review.

PMID:
25982505
15.

Trabecular Bone Score: Where are we now?

Bousson V, Bergot C, Sutter B, Thomas T, Bendavid S, Benhamou CL, Blain H, Brazier M, Breuil V, Briot K, Chapurlat R, Chapuis L, Cohen Solal M, Fardellone P, Feron JM, Gauvain JB, Laroche M, Legrand E, Lespessailles E, Linglart A, Marcelli C, Roux C, Souberbielle JC, Tremollieres F, Weryha G, Cortet B; Groupe de Recherche et d’Information sur les Ostéoporoses (GRIO).

Joint Bone Spine. 2015 Oct;82(5):320-5. doi: 10.1016/j.jbspin.2015.02.005. Epub 2015 Apr 24. Review.

PMID:
25921803
16.

[HRT and ovarian cancer risk].

Lopes P, Trémollières F, Gompel A.

Gynecol Obstet Fertil. 2015 Apr;43(4):324-5. doi: 10.1016/j.gyobfe.2015.02.015. Epub 2015 Mar 26. French. No abstract available.

PMID:
25819391
17.

EMAS position statement: The ten point guide to the integral management of menopausal health.

Neves-E-Castro M, Birkhauser M, Samsioe G, Lambrinoudaki I, Palacios S, Borrego RS, Llaneza P, Ceausu I, Depypere H, Erel CT, Pérez-López FR, Schenck-Gustafsson K, van der Schouw YT, Simoncini T, Tremollieres F, Rees M.

Maturitas. 2015 May;81(1):88-92. doi: 10.1016/j.maturitas.2015.02.003. Epub 2015 Feb 11.

PMID:
25757366
18.

EMAS position statement: individualized breast cancer screening versus population-based mammography screening programmes.

Depypere H, Desreux J, Pérez-López FR, Ceausu I, Erel CT, Lambrinoudaki I, Schenck-Gustafsson K, van der Schouw YT, Simoncini T, Tremollieres F, Rees M, EMAS.

Maturitas. 2014 Dec;79(4):481-6. doi: 10.1016/j.maturitas.2014.09.002. Epub 2014 Sep 16.

PMID:
25277123
19.

[Weakening osteopathies, chronic kidney disease, malabsorption, biological anomalies of calium/phosphorus metabolism: appropriate indications for a reasoned reimbursment of serum vitamin D measurement].

Souberbielle JC, Benhamou CL, Cortet B, Rousière M, Roux C, Abitbol V, Annweiler C, Audran M, Bacchetta J, Bataille P, Beauchet O, Bardet R, Benachi A, Berenbaum F, Blain H, Borson-Chazot F, Breuil V, Briot K, Brunet P, Carel JC, Caron P, Chabre O, Chanson P, Chapurlat R, Cochat P, Coutant R, Christin-Maitre S, Cohen-Solal M, Combe C, Cormier C, Courbebaisse M, Debrus G, Delemer B, Deschenes G, Duquenne M, Fardellone P, Fouque D, Friedlander G, Gauvain JB, Groussin L, Guggenbuhl P, Houillier P, Hannedouche T, Jacot W, Javier RM, Jean G, Jeandel C, Joly D, Kamenicky P, Knebelmann B, Lafage-Proust MH, LeBouc Y, Legrand E, Levy-Weil F, Linglart A, Machet L, Maheu E, Mallet E, Marcelli C, Marès P, Mariat C, Maruani G, Maugars Y, Montagnon F, Moulin B, Orcel P, Partouche H, Personne V, Pierrot-Deseilligny C, Polak M, Pouteil-Noble C, Prié D, Raynaud-Simon A, Rolland Y, Sadoul JL, Salle B, Sault C, Schott AM, Sermet-Gaudelus I, Soubrier M, Tack I, Thervet É, Tostivint I, Touraine P, Tremollières F, Urena-Torres P, Viard JP, Wemeau JL, Weryha G, Winer N, Young J, Thomas T.

Ann Biol Clin (Paris). 2014 Jul-Aug;72(4):385-9. doi: 10.1684/abc.2014.0972. French. No abstract available.

20.

EMAS position statement: management of uterine fibroids.

Pérez-López FR, Ornat L, Ceausu I, Depypere H, Erel CT, Lambrinoudaki I, Schenck-Gustafsson K, Simoncini T, Tremollieres F, Rees M; EMAS.

Maturitas. 2014 Sep;79(1):106-16. doi: 10.1016/j.maturitas.2014.06.002. Epub 2014 Jun 9.

PMID:
24975954

Supplemental Content

Loading ...
Support Center